• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新辅助隔离肢体灌注和肿瘤切除治疗原发性非转移性软组织肉瘤的肿瘤学结果。

Oncological outcome of primary non-metastatic soft tissue sarcoma treated by neoadjuvant isolated limb perfusion and tumor resection.

机构信息

Division of Surgical Oncology and Thoracic Surgery, Department of Surgery, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.

出版信息

J Surg Oncol. 2014 Jun;109(8):786-90. doi: 10.1002/jso.23591. Epub 2014 Mar 12.

DOI:10.1002/jso.23591
PMID:24619722
Abstract

BACKGROUND

Isolated limb perfusion (ILP) is an effective limb salvage strategy in patients with advanced soft tissue sarcoma (STS) where surgery alone would result in significant functional morbidity or mandate an amputation. Most previous reports of patients undergoing ILP focus on limb salvage rates rather than local and distant relapse rates. Here, we report the oncological outcome of sarcoma patients treated by ILP and surgery.

METHODS

Data were retrieved from prospective ILP databases from two ILP centers following similar ILP techniques and surgical approaches. Only patients with primary, intermediate, or high grade non-metastatic STS were included.

RESULTS

The cohort comprised 90 patients. Median follow-up was 39 months (range 3-165 months). Median tumor size was 11 cm (range 5-34). Twenty of 90 (22%) patients underwent prior debulking surgery outside the centers. Twenty-nine of 90 (32%) had postoperative irradiation. Four of 90 underwent amputation either related to local recurrence or irresectability, 4 of 90 underwent amputation for treatment-related complications. Fifteen of 83 (18%) patients had local recurrences after ILP and limb sparing surgery, 39 of 90 (43%) developed metastatic disease. Twenty-two of 90 (24%) died of disease.

CONCLUSION

Preoperative ILP and tumor resection resulted in good local control in a cohort of high-risk STS patients.

摘要

背景

孤立肢体灌注(ILP)是一种有效的肢体保存策略,适用于单独手术会导致显著功能障碍或需要截肢的晚期软组织肉瘤(STS)患者。大多数接受 ILP 治疗的患者的报告重点是保肢率,而不是局部和远处复发率。在这里,我们报告了接受 ILP 和手术治疗的肉瘤患者的肿瘤学结果。

方法

从两个 ILP 中心的前瞻性 ILP 数据库中检索数据,这些中心采用类似的 ILP 技术和手术方法。仅纳入原发性、中间型或高级别非转移性 STS 的患者。

结果

该队列包括 90 名患者。中位随访时间为 39 个月(范围 3-165 个月)。中位肿瘤大小为 11cm(范围 5-34)。20/90(22%)名患者在中心外接受过先前的减瘤手术。29/90(32%)名患者术后接受了放疗。4/90 名患者因局部复发或无法切除而行截肢,4/90 名患者因治疗相关并发症而行截肢。15/83(18%)名接受 ILP 和保肢手术后的患者出现局部复发,90 名中有 39 名(43%)发生转移性疾病。22/90(24%)名患者因疾病死亡。

结论

在高危 STS 患者队列中,术前 ILP 和肿瘤切除导致良好的局部控制。

相似文献

1
Oncological outcome of primary non-metastatic soft tissue sarcoma treated by neoadjuvant isolated limb perfusion and tumor resection.新辅助隔离肢体灌注和肿瘤切除治疗原发性非转移性软组织肉瘤的肿瘤学结果。
J Surg Oncol. 2014 Jun;109(8):786-90. doi: 10.1002/jso.23591. Epub 2014 Mar 12.
2
Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities.采用肿瘤坏死因子-α和美法仑对四肢不可切除软组织肉瘤患者进行隔离肢体灌注。
Cancer. 2003 Oct 1;98(7):1483-90. doi: 10.1002/cncr.11648.
3
Evaluation of 47 soft tissue sarcoma resection specimens after isolated limb perfusion with TNF-alpha and melphalan: histologically characterized improved margins correlate with absence of recurrences.对47例经肿瘤坏死因子-α(TNF-α)和美法仑隔离肢体灌注后行软组织肉瘤切除的标本进行评估:组织学特征显示切缘改善与无复发相关。
Ann Surg Oncol. 2009 Mar;16(3):676-86. doi: 10.1245/s10434-008-0277-4. Epub 2009 Jan 6.
4
Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: long-term results on efficacy and limb salvage in a selected group of patients.使用肿瘤坏死因子和美法仑进行隔离肢体灌注治疗不可切除的软组织肉瘤:一组特定患者的长期疗效和肢体挽救结果
J Surg Oncol. 2008 Sep 1;98(3):148-55. doi: 10.1002/jso.21081.
5
Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.采用肿瘤坏死因子α和马法兰新辅助隔离灌注法保肢治疗四肢不可切除的软组织肉瘤。
Eur J Surg Oncol. 2000 Nov;26(7):669-78. doi: 10.1053/ejso.2000.0979.
6
Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma.217例连续应用肿瘤坏死因子-α和美法仑进行孤立肢体灌注治疗肢体威胁性软组织肉瘤的疗效及预后因素分析
Cancer. 2006 Apr 15;106(8):1776-84. doi: 10.1002/cncr.21802.
7
Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma.原发性局限性高级别软组织肉瘤患者新辅助隔离肢体灌注后的组织学反应评估。
Int J Hyperthermia. 2016;32(2):159-64. doi: 10.3109/02656736.2015.1109146. Epub 2015 Dec 15.
8
Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial.高剂量肿瘤坏死因子-α联合干扰素-γ和马法兰进行肢体隔离灌注治疗不可切除的肢体软组织肉瘤:一项多中心试验
J Clin Oncol. 1996 Oct;14(10):2653-65. doi: 10.1200/JCO.1996.14.10.2653.
9
Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: the value of adjuvant radiotherapy.肿瘤坏死因子α和美法仑隔离肢体灌注治疗局部晚期软组织肉瘤:辅助放疗的价值
Ann Surg Oncol. 2006 Apr;13(4):518-24. doi: 10.1245/ASO.2006.02.005. Epub 2006 Feb 16.
10
Impact of hyperthermic isolated limb perfusion on tumour oxygenation in soft tissue sarcoma.高热隔离肢体灌注对软组织肉瘤肿瘤氧合的影响。
Int J Hyperthermia. 2012;28(7):591-6. doi: 10.3109/02656736.2012.705945. Epub 2012 Sep 4.

引用本文的文献

1
Malignant adipocytic tumours: A 20‑year single‑centre retrospective study.恶性脂肪细胞肿瘤:一项为期20年的单中心回顾性研究。
Oncol Lett. 2023 Apr 21;25(6):247. doi: 10.3892/ol.2023.13833. eCollection 2023 Jun.
2
Neoadjuvant isolated limb perfusion in newly diagnosed untreated patients with locally advanced soft tissue sarcomas of the extremities: the Gustave Roussy experience.新诊断的未治疗的四肢局部晚期软组织肉瘤患者的新辅助隔离肢体灌注:Gustave Roussy 经验。
Clin Transl Oncol. 2019 Sep;21(9):1135-1141. doi: 10.1007/s12094-019-02034-w. Epub 2019 Jan 17.
3
Occurrence and prognosis of lymph node metastases in patients selected for isolated limb perfusion with soft tissue sarcoma.
接受软组织肉瘤隔离肢体灌注治疗患者的淋巴结转移发生率及预后
J Cancer. 2018 Sep 7;9(18):3311-3315. doi: 10.7150/jca.25696. eCollection 2018.
4
Regional chemotherapy by isolated limb perfusion prior to surgery compared with surgery and post-operative radiotherapy for primary, locally advanced extremity sarcoma: a comparison of matched cohorts.术前经肢体隔离灌注进行区域化疗与手术及术后放疗治疗原发性局部晚期肢体肉瘤的比较:匹配队列的对比研究
Clin Sarcoma Res. 2018 Jul 2;8:12. doi: 10.1186/s13569-018-0098-6. eCollection 2018.
5
Therapeutic options and postoperative wound complications after extremity soft tissue sarcoma resection and postoperative external beam radiotherapy.四肢软组织肉瘤切除术后和术后外照射放疗后的治疗选择和术后伤口并发症。
Int Wound J. 2018 Feb;15(1):148-158. doi: 10.1111/iwj.12851. Epub 2017 Dec 5.
6
Lower limb function and quality of life after ILP for soft-tissue sarcoma.软组织肉瘤行隔离肢体灌注术后的下肢功能与生活质量
World J Surg Oncol. 2017 Apr 13;15(1):84. doi: 10.1186/s12957-017-1150-3.
7
Isolated limb perfusion with biochemotherapy and oncolytic virotherapy combines with radiotherapy and surgery to overcome treatment resistance in an animal model of extremity soft tissue sarcoma.在肢体软组织肉瘤动物模型中,生物化疗和溶瘤病毒疗法联合隔离肢体灌注与放疗及手术相结合,以克服治疗抵抗。
Int J Cancer. 2016 Sep 15;139(6):1414-22. doi: 10.1002/ijc.30162. Epub 2016 May 24.
8
[Interdisciplinary treatment of soft tissue sarcoma of the extremities].[肢体软组织肉瘤的多学科治疗]
Chirurg. 2014 May;85(5):383-90. doi: 10.1007/s00104-013-2689-3.